Skip to main content
Book cover

Systems Biology

Integrative Biology and Simulation Tools

  • Book
  • © 2013

Overview

  • This multi-authored volume presents a unique update in the field of pharmaceutical drugs
  • The book presents a unique coverage of computational problems and tools related to this field
  • The selected authors are all experts in their field

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (19 chapters)

  1. Foundation of Systems Biology, Integrative Biology and Issues of Biosystem Complexity, Redundancy and of Other Network Properties

  2. Modeling of Ill-Defined, Lack of Knowledge (Experimental) Problems in the Field of Complex Biosystems Including Identification and Validation: A Review of Enabling Technologies

  3. Critical Analysis of Multi-Scale Computational Methods and Tools, Computational Tools for Crossing Levels and Applications

Keywords

About this book

Growth in the pharmaceutical market has slowed down – almost to a standstill. One reason is that governments and other payers are cutting costs in a faltering world economy. But a more fundamental problem is the failure of major companies to discover, develop and market new drugs. Major drugs losing patent protection or being withdrawn from the market are simply not being replaced by new therapies – the pharmaceutical market model is no longer functioning effectively and most pharmaceutical companies are failing to produce the innovation needed for success. This multi-authored new book looks at a vital strategy which can bring innovation to a market in need of new ideas and new products: Systems Biology (SB). Modeling is a significant task of systems biology. SB aims to develop and use efficient algorithms, data structures, visualization and communication tools to orchestrate the integration of large quantities of biological data with the goal of computer modeling. It involves the use of computer simulations of biological systems, such as the networks of metabolites comprise signal transduction pathways and gene regulatory networks to both analyze and visualize the complex connections of these cellular processes. SB involves a series of operational protocols used for performing research, namely a cycle composed of theoretical, analytic or computational modeling to propose specific testable hypotheses about a biological system, experimental validation, and then using the newly acquired quantitative description of cells or cell processes to refine the computational model or theory.

Reviews

From the reviews:

“This volume is the first of three planned books exploring the various tools used by the scientific community to deal with complexity in subjects such as big data, nonlinearity, and hidden interactions in systems biology. … welcomed by readers … who are directly or indirectly involved in the dynamic field of systems biology. The book offers insightful connections, knowledge that is often overlooked, and well-thought-out reasoning.” (Adrian Pasculescu, Computing Reviews, January, 2014)

Editors and Affiliations

  • Chemical and Biological Engineering, Vanderbilt University, Nashville, USA

    Aleš Prokop

  • Research Group on Process Network Engineering, Kaposvár University, Kaposvár, Hungary

    Béla Csukás

Bibliographic Information

Publish with us